1. Degradation of phosphorylated p53 by viral protein-ECS E3 ligase complex
- Author
-
Takayuki Murata, Noriko Shirata, Hiroki Isomura, Sanae Nakayama, Takumi Kamura, Ayumi Kudoh, Yukihiro Nishiyama, Satoko Iwahori, Tatsuya Tsurumi, and Yoshitaka Sato
- Subjects
lcsh:Immunologic diseases. Allergy ,Herpesvirus 4, Human ,Viral protein ,Ubiquitin-Protein Ligases ,viruses ,Immunology ,Amino Acid Motifs ,Molecular Sequence Data ,medicine.disease_cause ,Virus Replication ,Microbiology ,Cell Biology/Cell Signaling ,Cell Line ,Cell Line, Tumor ,Virology ,Genetics ,medicine ,Humans ,Amino Acid Sequence ,Phosphorylation ,Molecular Biology ,lcsh:QH301-705.5 ,chemistry.chemical_classification ,DNA ligase ,biology ,Ubiquitination ,Cullin Proteins ,Molecular biology ,Ubiquitin ligase ,BZLF1 ,Viral replication ,Lytic cycle ,chemistry ,lcsh:Biology (General) ,Ubiquitin ligase complex ,Molecular Biology/Post-Translational Regulation of Gene Expression ,biology.protein ,Trans-Activators ,Mdm2 ,Parasitology ,Tumor Suppressor Protein p53 ,lcsh:RC581-607 ,Research Article - Abstract
p53-signaling is modulated by viruses to establish a host cellular environment advantageous for their propagation. The Epstein-Barr virus (EBV) lytic program induces phosphorylation of p53, which prevents interaction with MDM2. Here, we show that induction of EBV lytic program leads to degradation of p53 via an ubiquitin-proteasome pathway independent of MDM2. The BZLF1 protein directly functions as an adaptor component of the ECS (Elongin B/C-Cul2/5-SOCS-box protein) ubiquitin ligase complex targeting p53 for degradation. Intringuingly, C-terminal phosphorylation of p53 resulting from activated DNA damage response by viral lytic replication enhances its binding to BZLF1 protein. Purified BZLF1 protein-associated ECS could be shown to catalyze ubiquitination of phospho-mimetic p53 more efficiently than the wild-type in vitro. The compensation of p53 at middle and late stages of the lytic infection inhibits viral DNA replication and production during lytic infection, suggesting that the degradation of p53 is required for efficient viral propagation. Taken together, these findings demonstrate a role for the BZLF1 protein-associated ECS ligase complex in regulation of p53 phosphorylated by activated DNA damage signaling during viral lytic infection., Author Summary Inhibition of p53-mediated transactivation is essential for regulating the cellular environment advantageous for viral infection. Specially, DNA viruses target p53 for inactivation through the ubiquitin-proteasome pathway. The E6 protein of the high-risk human papillomaviruses and the cellular ubiquitin-protein ligase E6AP form a complex which causes ubiquitination and degradation of p53. The adenovirus E1B 55-kDa protein binds to both p53 and E4orf6, and recruits a Cullin-containing complex to direct the ubiquitin-mediated proteolysis of p53. However, in comparison with the effects of the smaller DNA viruses, much less is known regarding the precise mechanisms whereby the Epstein-Barr virus (EBV) inhibits functions of p53. EBV possesses two alternative life cycles, latent and lytic replication. In latent phase, p53 is regulated by MDM2 ubiquitin ligase while after induction of lytic replication p53 is phosphorylated and the level of activated p53 is regulated by a novel system independent of MDM2. This report describes a unique functional role of the BZLF1 protein encoded by EBV in the modulation of activated p53. In this pathway, BZLF1 protein serves as an adaptor molecule for both Cul2- and Cul5-containing E3 ubiquitin ligase complexes to stimulate the ubiquitination and degradation of p53 for inhibiting apoptosis, indicating redundancy in the EBV machinery to downregulate p53 level. Therefore, it would be possible that the complexes regulate not only p53 but also various proteins that interact with BZLF1 protein.
- Published
- 2009